Israel Englander’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.9M | Buy |
135,300
+65,300
| +93% | +$6.27M | ﹤0.01% | 2033 |
|
|
2026
Q1 | $7.25M | Buy |
70,000
+27,800
| +66% | +$3.15M | ﹤0.01% | 2530 |
|
|
2025
Q4 | $4.26M | Buy |
42,200
+8,400
| +25% | +$912K | ﹤0.01% | 3192 |
|
|
2025
Q3 | $4.17M | Sell |
33,800
-22,800
| -40% | -$2.83M | ﹤0.01% | 3331 |
|
|
2025
Q2 | $6.8M | Buy |
56,600
+47,800
| +543% | +$6.38M | ﹤0.01% | 2659 |
|
|
2025
Q1 | $1.3M | Sell |
8,800
-5,500
| -38% | -$840K | ﹤0.01% | 4153 |
|
|
2024
Q4 | $2.32M | Sell |
14,300
-14,300
| -50% | -$2.34M | ﹤0.01% | 3507 |
|
|
2024
Q3 | $4.66M | Buy |
28,600
+7,700
| +37% | +$1.14M | ﹤0.01% | 2905 |
|
|
2024
Q2 | $2.85M | Sell |
20,900
-130,800
| -86% | -$18.2M | ﹤0.01% | 3211 |
|
|
2024
Q1 | $23.2M | Buy |
151,700
+100,000
| +193% | +$14.9M | 0.01% | 1445 |
|
|
2023
Q4 | $7.37M | Buy |
51,700
+38,200
| +283% | +$5.09M | ﹤0.01% | 2463 |
|
|
2023
Q3 | $1.77M | Buy |
13,500
+11,500
| +575% | +$1.75M | ﹤0.01% | 3676 |
|
|
2023
Q2 | $318K | Sell |
2,000
-3,100
| -61% | -$500K | ﹤0.01% | 4843 |
|
|
2023
Q1 | $807K | Sell |
5,100
-20,100
| -80% | -$3.01M | ﹤0.01% | 4285 |
|
|
2022
Q4 | $3.54M | Sell |
25,200
-8,400
| -25% | -$1.19M | ﹤0.01% | 3094 |
|
|
2022
Q3 | $4.31M | Sell |
33,600
-295,200
| -90% | -$42.6M | ﹤0.01% | 3037 |
|
|
2022
Q2 | $46.4M | Buy |
+328,800
| New | +$47M | 0.03% | 700 |
|
|
2021
Q2 | – | Sell |
-1,600
| Closed | -$309K | – | 6579 |
|
|
2021
Q1 | $309K | Sell |
1,600
-20,500
| -93% | -$3.95M | ﹤0.01% | 5192 |
|
|
2020
Q4 | $4.46M | Hold |
22,100
| – | – | ﹤0.01% | 2558 |
|
|
2020
Q3 | $4.64K | Sell |
22,100
-1,100
| -5% | -$245K | 0.01% | 1912 |
|
|
2020
Q2 | $5.09M | Buy |
+23,200
| New | +$4.64M | 0.01% | 1751 |
|
|
2019
Q4 | – | Sell |
-158,900
| Closed | -$24.1M | – | 4254 |
|
|
2019
Q3 | $24.1M | Buy |
158,900
+150,200
| +1,726% | +$23.7M | 0.04% | 658 |
|
|
2019
Q2 | $1.33M | Buy |
+8,700
| New | +$1.33M | ﹤0.01% | 2632 |
|
|
2018
Q4 | – | Sell |
-13,000
| Closed | -$1.96M | – | 3792 |
|
|
2018
Q3 | $1.96M | Buy |
13,000
+6,500
| +100% | +$923K | ﹤0.01% | 2456 |
|
|
2018
Q2 | $879K | Buy |
+6,500
| New | +$802K | ﹤0.01% | 2912 |
|
|
2014
Q2 | – | Sell |
-8,800
| Closed | -$774K | – | 3449 |
|
|
2014
Q1 | $774K | Buy |
8,800
+5,400
| +159% | +$474K | ﹤0.01% | 2379 |
|
|
2013
Q4 | $315K | Buy |
+3,400
| New | +$306K | ﹤0.01% | 3006 |
|
Other funds holding CLX
Israel Englander's CLX Position: Q2 2026 in Review
Israel Englander increased its Clorox (CLX) stake by 200% in Q2 2026, buying an estimated $133M and bringing the position to 2,073,010 shares worth $198M. The position accounts for 0.07% of the portfolio, ranked #246.
Israel Englander first reported a position in CLX in Q3 2013 and has held it in 49 quarters since. The position peaked at $216M in Q4 2023. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Israel Englander held 2,073,010 shares of Clorox worth $198M as of Q2 2026.
- Israel Englander bought 1,381,163 Clorox shares in Q2 2026, an estimated $133M.
- Clorox made up 0.07% of Israel Englander's portfolio in Q2 2026, its #246 holding.
- Israel Englander first reported a position in Clorox in Q3 2013 and has held it in 49 quarters since.
- Israel Englander's Clorox position peaked at $216M in Q4 2023.
- 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.